-
CDT Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Conduit Pharmaceuticals (CDT)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 71.00 k | 71.00 k | 71.00 k | 71.00 k | 71.00 k | 71.00 k |
Cash burn (monthly) | 591.00 k | (no burn) | 1.94 mm | 968.75 k | 666.33 k | 806.92 k |
Cash used (since last report) | 1.66 mm | n/a | 5.46 mm | 2.73 mm | 1.88 mm | 2.27 mm |
Cash remaining | -1.59 mm | n/a | -5.39 mm | -2.66 mm | -1.81 mm | -2.20 mm |
Runway (months of cash) | -2.7 | n/a | -2.8 | -2.7 | -2.7 | -2.7 |
13F holders | Current |
---|---|
Total holders | 22 |
Opened positions | 18 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 188.34 mm |
Total shares | 51.15 mm |
Total puts | 0.00 |
Total calls | 284.50 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Corvus Capital | 30.05 mm | $93.15 mm |
Nirland | 6.52 mm | $0.00 |
St George Street Capital | 4.75 mm | $0.00 |
Murphy Canyon Acquisition Sponsor | 4.72 mm | $0.00 |
Polar Asset Management Partners | 950.00 k | $14.73 mm |
Saba Capital Management | 765.00 k | $25.05 mm |
Exos Asset Management | 554.75 k | $8.60 mm |
Walleye Capital | 516.03 k | $8.00 mm |
D. E. Shaw & Co. | 375.00 k | $5.78 mm |
Walleye Trading | 290.27 k | $4.50 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Dec 24 | Simon Jeremy Fry | Stock Option Common Stock | Grant | Acquire A | No | No | 0.071 | 420,000 | 29.82 k | 420,000 |
18 Dec 24 | Chele Chiavacci Farley | Stock Option Common Stock | Grant | Acquire A | No | No | 0.071 | 420,000 | 29.82 k | 420,000 |
18 Dec 24 | Faith L. Charles | Stock Option Common Stock | Grant | Acquire A | No | No | 0.071 | 420,000 | 29.82 k | 420,000 |
18 Dec 24 | Lewis-Hall Freda C | Stock Option Common Stock | Grant | Acquire A | No | No | 0.071 | 420,000 | 29.82 k | 420,000 |